Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rheumatoid Arthritis
Pharma
Galapagos sells its Jyseleca business to Italy's Alfasigma
Galapagos has agreed to sell its Jyseleca business to Alfasigma. Around 400 Galapagos employees will join the Italian company under the deal.
Kevin Dunleavy
Oct 31, 2023 9:10am
Biogen nabs FDA nod for biosimilar of Roche blockbuster Actemra
Oct 2, 2023 10:42am
Roche sues Biogen over Actemra biosimilar infringement claims
Jul 17, 2023 9:45am
With FDA nod for Crohn's, AbbVie wins 7th indication for Rinvoq
May 18, 2023 4:25pm
EMA cracks down on JAK drugs with new limitations
Oct 28, 2022 10:20am
ANI focuses on data insights to ramp up Cortrophin
Jun 24, 2022 8:10am
